Publication Information

{'id': 'https://openalex.org/W4283711720', 'doi': 'https://doi.org/10.1136/annrheumdis-2022-eular.1563', 'title': 'POS0676 EFFICACY AND SAFETY OF FILGOTINIB IN PATIENTS AGED ≥75 YEARS: A POST HOC SUBGROUP ANALYSIS OF THE FINCH 4 LONG-TERM EXTENSION (LTE) STUDY', 'display_name': 'POS0676 EFFICACY AND SAFETY OF FILGOTINIB IN PATIENTS AGED ≥75 YEARS: A POST HOC SUBGROUP ANALYSIS OF THE FINCH 4 LONG-TERM EXTENSION (LTE) STUDY', 'publication_year': 2022, 'publication_date': '2022-05-23', 'ids': {'openalex': 'https://openalex.org/W4283711720', 'doi': 'https://doi.org/10.1136/annrheumdis-2022-eular.1563'}, 'language': 'en', 'primary_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1136/annrheumdis-2022-eular.1563', 'pdf_url': 'https://ard.bmj.com/content/annrheumdis/81/Suppl_1/612.2.full.pdf', 'source': {'id': 'https://openalex.org/S25650217', 'display_name': 'Annals of the Rheumatic Diseases', 'issn_l': '0003-4967', 'issn': ['0003-4967', '1468-2060'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319945', 'host_organization_name': 'BMJ', 'host_organization_lineage': ['https://openalex.org/P4310319945'], 'host_organization_lineage_names': ['BMJ'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': True, 'oa_status': 'bronze', 'oa_url': 'https://ard.bmj.com/content/annrheumdis/81/Suppl_1/612.2.full.pdf', 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5061411814', 'display_name': 'Daniel Aletaha', 'orcid': 'https://orcid.org/0000-0003-2108-0030'}, 'institutions': [{'id': 'https://openalex.org/I76134821', 'display_name': 'Medical University of Vienna', 'ror': 'https://ror.org/05n3x4p02', 'country_code': 'AT', 'type': 'education', 'lineage': ['https://openalex.org/I76134821']}], 'countries': ['AT'], 'is_corresponding': False, 'raw_author_name': 'D. Aletaha', 'raw_affiliation_strings': ['Medical University of Vienna, Department of Medicine III (Division of Rheumatology), Vienna, Austria'], 'affiliations': [{'raw_affiliation_string': 'Medical University of Vienna, Department of Medicine III (Division of Rheumatology), Vienna, Austria', 'institution_ids': ['https://openalex.org/I76134821']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5049908897', 'display_name': 'R. Westhovens', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I99464096', 'display_name': 'KU Leuven', 'ror': 'https://ror.org/05f950310', 'country_code': 'BE', 'type': 'education', 'lineage': ['https://openalex.org/I99464096']}], 'countries': ['BE'], 'is_corresponding': False, 'raw_author_name': 'R. Westhovens', 'raw_affiliation_strings': ['University Hospitals Leuven, Department of Rheumatology, Leuven, Belgium'], 'affiliations': [{'raw_affiliation_string': 'University Hospitals Leuven, Department of Rheumatology, Leuven, Belgium', 'institution_ids': ['https://openalex.org/I99464096']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5048584658', 'display_name': 'B. Combe', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I19894307', 'display_name': 'Université de Montpellier', 'ror': 'https://ror.org/051escj72', 'country_code': 'FR', 'type': 'education', 'lineage': ['https://openalex.org/I19894307']}], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'B. Combe', 'raw_affiliation_strings': ['Montpellier University, Department of Rheumatology, Montpellier, France'], 'affiliations': [{'raw_affiliation_string': 'Montpellier University, Department of Rheumatology, Montpellier, France', 'institution_ids': ['https://openalex.org/I19894307']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5107869788', 'display_name': 'Jacques-Éric Gottenberg', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I68947357', 'display_name': 'Université de Strasbourg', 'ror': 'https://ror.org/00pg6eq24', 'country_code': 'FR', 'type': 'education', 'lineage': ['https://openalex.org/I68947357']}], 'countries': ['FR'], 'is_corresponding': False, 'raw_author_name': 'J. E. Gottenberg', 'raw_affiliation_strings': ['Strasbourg University Hospital, Rheumatology Department, Strasbourg, France'], 'affiliations': [{'raw_affiliation_string': 'Strasbourg University Hospital, Rheumatology Department, Strasbourg, France', 'institution_ids': ['https://openalex.org/I68947357']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5013618587', 'display_name': 'M. H. Buch', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I28407311', 'display_name': 'University of Manchester', 'ror': 'https://ror.org/027m9bs27', 'country_code': 'GB', 'type': 'education', 'lineage': ['https://openalex.org/I28407311']}], 'countries': ['GB'], 'is_corresponding': False, 'raw_author_name': 'M. H. Buch', 'raw_affiliation_strings': ['The University of Manchester, Centre for Musculoskeletal Research, Division of Musculoskeletal & Dermatological Sciences, Faculty of Medicine & Health, Manchester, United Kingdom'], 'affiliations': [{'raw_affiliation_string': 'The University of Manchester, Centre for Musculoskeletal Research, Division of Musculoskeletal & Dermatological Sciences, Faculty of Medicine & Health, Manchester, United Kingdom', 'institution_ids': ['https://openalex.org/I28407311']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5069330674', 'display_name': 'R. Caporali', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I189158943', 'display_name': 'University of Milan', 'ror': 'https://ror.org/00wjc7c48', 'country_code': 'IT', 'type': 'education', 'lineage': ['https://openalex.org/I189158943']}], 'countries': ['IT'], 'is_corresponding': False, 'raw_author_name': 'R. Caporali', 'raw_affiliation_strings': ['The University of Milan, Department of Clinical Sciences and Community Health, Milan, Italy'], 'affiliations': [{'raw_affiliation_string': 'The University of Milan, Department of Clinical Sciences and Community Health, Milan, Italy', 'institution_ids': ['https://openalex.org/I189158943']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5048687810', 'display_name': 'J. A. Gómez-Puerta', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210115097', 'display_name': 'Hospital Clínic de Barcelona', 'ror': 'https://ror.org/02a2kzf50', 'country_code': 'ES', 'type': 'healthcare', 'lineage': ['https://openalex.org/I4210115097']}], 'countries': ['ES'], 'is_corresponding': False, 'raw_author_name': 'J. A. Gómez-Puerta', 'raw_affiliation_strings': ['Hospital Clinic of Barcelona, Department of Rheumatology, Barcelona, Spain'], 'affiliations': [{'raw_affiliation_string': 'Hospital Clinic of Barcelona, Department of Rheumatology, Barcelona, Spain', 'institution_ids': ['https://openalex.org/I4210115097']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5014361894', 'display_name': 'P. Van Hoek', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I85459889', 'display_name': 'Galapagos (Belgium)', 'ror': 'https://ror.org/04e4j5d46', 'country_code': 'BE', 'type': 'company', 'lineage': ['https://openalex.org/I85459889']}], 'countries': ['BE'], 'is_corresponding': False, 'raw_author_name': 'P. Van Hoek', 'raw_affiliation_strings': ['Galapagos NV, Clinical Development, Mechelen, Belgium'], 'affiliations': [{'raw_affiliation_string': 'Galapagos NV, Clinical Development, Mechelen, Belgium', 'institution_ids': ['https://openalex.org/I85459889']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5041018063', 'display_name': 'V. Rajendran', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I85459889', 'display_name': 'Galapagos (Belgium)', 'ror': 'https://ror.org/04e4j5d46', 'country_code': 'BE', 'type': 'company', 'lineage': ['https://openalex.org/I85459889']}], 'countries': ['BE'], 'is_corresponding': False, 'raw_author_name': 'V. Rajendran', 'raw_affiliation_strings': ['Galapagos NV, Clinical Development, Mechelen, Belgium'], 'affiliations': [{'raw_affiliation_string': 'Galapagos NV, Clinical Development, Mechelen, Belgium', 'institution_ids': ['https://openalex.org/I85459889']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5011229981', 'display_name': 'P. J. Stiers', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I85459889', 'display_name': 'Galapagos (Belgium)', 'ror': 'https://ror.org/04e4j5d46', 'country_code': 'BE', 'type': 'company', 'lineage': ['https://openalex.org/I85459889']}], 'countries': ['BE'], 'is_corresponding': False, 'raw_author_name': 'P. J. Stiers', 'raw_affiliation_strings': ['Galapagos NV, Biostatistics, Mechelen, Belgium'], 'affiliations': [{'raw_affiliation_string': 'Galapagos NV, Biostatistics, Mechelen, Belgium', 'institution_ids': ['https://openalex.org/I85459889']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5027953080', 'display_name': 'T. Hendrikx', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210140915', 'display_name': 'Galapagos (Netherlands)', 'ror': 'https://ror.org/04e7m9p55', 'country_code': 'NL', 'type': 'company', 'lineage': ['https://openalex.org/I4210140915', 'https://openalex.org/I85459889']}], 'countries': ['NL'], 'is_corresponding': False, 'raw_author_name': 'T. Hendrikx', 'raw_affiliation_strings': ['Galapagos NV, Medical Affairs, Leiden, Netherlands'], 'affiliations': [{'raw_affiliation_string': 'Galapagos NV, Medical Affairs, Leiden, Netherlands', 'institution_ids': ['https://openalex.org/I4210140915']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5076851275', 'display_name': 'Gerd R Burmester', 'orcid': 'https://orcid.org/0000-0001-7518-1131'}, 'institutions': [{'id': 'https://openalex.org/I7877124', 'display_name': 'Charité - Universitätsmedizin Berlin', 'ror': 'https://ror.org/001w7jn25', 'country_code': 'DE', 'type': 'healthcare', 'lineage': ['https://openalex.org/I7877124']}], 'countries': ['DE'], 'is_corresponding': False, 'raw_author_name': 'G. R. Burmester', 'raw_affiliation_strings': ['Charité University Hospital, Department of Rheumatology and Clinical Immunology, Berlin, Germany'], 'affiliations': [{'raw_affiliation_string': 'Charité University Hospital, Department of Rheumatology and Clinical Immunology, Berlin, Germany', 'institution_ids': ['https://openalex.org/I7877124']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5075295962', 'display_name': 'Y. Tanaka', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I188700360', 'display_name': 'University of Occupational and Environmental Health Japan', 'ror': 'https://ror.org/020p3h829', 'country_code': 'JP', 'type': 'education', 'lineage': ['https://openalex.org/I188700360']}], 'countries': ['JP'], 'is_corresponding': False, 'raw_author_name': 'Y. Tanaka', 'raw_affiliation_strings': ['University of Occupational and Environmental Health, Internal Medicine, Kitakyushu, Japan'], 'affiliations': [{'raw_affiliation_string': 'University of Occupational and Environmental Health, Internal Medicine, Kitakyushu, Japan', 'institution_ids': ['https://openalex.org/I188700360']}]}], 'institution_assertions': [], 'countries_distinct_count': 9, 'institutions_distinct_count': 11, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 0.288, 'has_fulltext': False, 'cited_by_count': 1, 'citation_normalized_percentile': {'value': 0.556131, 'is_in_top_1_percent': False, 'is_in_top_10_percent': False}, 'cited_by_percentile_year': {'min': 60, 'max': 70}, 'biblio': {'volume': '81', 'issue': 'Suppl 1', 'first_page': '612.2', 'last_page': '613'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T11157', 'display_name': 'Chronic Lymphocytic Leukemia Research', 'score': 0.9975, 'subfield': {'id': 'https://openalex.org/subfields/2716', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T11157', 'display_name': 'Chronic Lymphocytic Leukemia Research', 'score': 0.9975, 'subfield': {'id': 'https://openalex.org/subfields/2716', 'display_name': 'Genetics'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11215', 'display_name': 'Chronic Myeloid Leukemia Treatments', 'score': 0.9867, 'subfield': {'id': 'https://openalex.org/subfields/2720', 'display_name': 'Hematology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11730', 'display_name': 'Autoimmune Bullous Skin Diseases', 'score': 0.9705, 'subfield': {'id': 'https://openalex.org/subfields/2734', 'display_name': 'Pathology and Forensic Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/post-hoc-analysis', 'display_name': 'Post-hoc analysis', 'score': 0.7769984}, {'id': 'https://openalex.org/keywords/post-hoc', 'display_name': 'Post hoc', 'score': 0.559247}, {'id': 'https://openalex.org/keywords/subgroup-analysis', 'display_name': 'Subgroup analysis', 'score': 0.45990038}], 'concepts': [{'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.938799}, {'id': 'https://openalex.org/C67761136', 'wikidata': 'https://www.wikidata.org/wiki/Q2105849', 'display_name': 'Post-hoc analysis', 'level': 2, 'score': 0.7769984}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.64702666}, {'id': 'https://openalex.org/C2777575956', 'wikidata': 'https://www.wikidata.org/wiki/Q187255', 'display_name': 'Rheumatoid arthritis', 'level': 2, 'score': 0.55985504}, {'id': 'https://openalex.org/C2992886853', 'wikidata': 'https://www.wikidata.org/wiki/Q18381816', 'display_name': 'Post hoc', 'level': 2, 'score': 0.559247}, {'id': 'https://openalex.org/C61511704', 'wikidata': 'https://www.wikidata.org/wiki/Q1671857', 'display_name': 'Incidence (geometry)', 'level': 2, 'score': 0.54264885}, {'id': 'https://openalex.org/C197934379', 'wikidata': 'https://www.wikidata.org/wiki/Q2047938', 'display_name': 'Adverse effect', 'level': 2, 'score': 0.5375523}, {'id': 'https://openalex.org/C187960798', 'wikidata': 'https://www.wikidata.org/wiki/Q7631152', 'display_name': 'Subgroup analysis', 'level': 3, 'score': 0.45990038}, {'id': 'https://openalex.org/C535046627', 'wikidata': 'https://www.wikidata.org/wiki/Q30612', 'display_name': 'Clinical trial', 'level': 2, 'score': 0.43878755}, {'id': 'https://openalex.org/C1862650', 'wikidata': 'https://www.wikidata.org/wiki/Q186005', 'display_name': 'Physical therapy', 'level': 1, 'score': 0.39395982}, {'id': 'https://openalex.org/C44249647', 'wikidata': 'https://www.wikidata.org/wiki/Q208498', 'display_name': 'Confidence interval', 'level': 2, 'score': 0.19328508}, {'id': 'https://openalex.org/C121332964', 'wikidata': 'https://www.wikidata.org/wiki/Q413', 'display_name': 'Physics', 'level': 0, 'score': 0.0}, {'id': 'https://openalex.org/C120665830', 'wikidata': 'https://www.wikidata.org/wiki/Q14620', 'display_name': 'Optics', 'level': 1, 'score': 0.0}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': True, 'landing_page_url': 'https://doi.org/10.1136/annrheumdis-2022-eular.1563', 'pdf_url': 'https://ard.bmj.com/content/annrheumdis/81/Suppl_1/612.2.full.pdf', 'source': {'id': 'https://openalex.org/S25650217', 'display_name': 'Annals of the Rheumatic Diseases', 'issn_l': '0003-4967', 'issn': ['0003-4967', '1468-2060'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319945', 'host_organization_name': 'BMJ', 'host_organization_lineage': ['https://openalex.org/P4310319945'], 'host_organization_lineage_names': ['BMJ'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}], 'best_oa_location': {'is_oa': True, 'landing_page_url': 'https://doi.org/10.1136/annrheumdis-2022-eular.1563', 'pdf_url': 'https://ard.bmj.com/content/annrheumdis/81/Suppl_1/612.2.full.pdf', 'source': {'id': 'https://openalex.org/S25650217', 'display_name': 'Annals of the Rheumatic Diseases', 'issn_l': '0003-4967', 'issn': ['0003-4967', '1468-2060'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310319945', 'host_organization_name': 'BMJ', 'host_organization_lineage': ['https://openalex.org/P4310319945'], 'host_organization_lineage_names': ['BMJ'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': 'publishedVersion', 'is_accepted': True, 'is_published': True}, 'sustainable_development_goals': [{'display_name': 'Good health and well-being', 'id': 'https://metadata.un.org/sdg/3', 'score': 0.62}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4389368569', 'https://openalex.org/W4383421632', 'https://openalex.org/W3014788916', 'https://openalex.org/W2995377144', 'https://openalex.org/W2182025991', 'https://openalex.org/W2177703973', 'https://openalex.org/W2111390454', 'https://openalex.org/W2087491399', 'https://openalex.org/W1973035946', 'https://openalex.org/W1500340015'], 'abstract_inverted_index': {'Background': [0], 'Filgotinib': [1], '(FIL)': [2], 'is': [3, 29, 41, 60, 99], 'a': [4, 34, 116, 361], 'Janus': [5], 'kinase': [6], '1': [7, 20, 55, 129], 'preferential': [8], 'inhibitor': [9], 'for': [10, 25, 43, 111, 208, 619], 'the': [11, 61, 70, 78, 304, 325, 356, 366, 613, 686, 693], 'treatment': [12], 'of': [13, 37, 51, 65, 82, 107, 123, 162, 191, 279, 284, 306, 327, 368, 377, 387, 588, 605, 638, 717], 'moderate': [14], 'to': [15, 73, 309, 365, 452, 470, 625, 659], 'severe': [16], 'rheumatoid': [17], 'arthritis': [18], '(RA)': [19], '.': [21, 56], 'The': [22, 274, 636, 671], 'recommended': [23, 42], 'dose': [24, 36, 347], 'adults': [26], 'with': [27, 88, 226, 239, 249, 321, 632], 'RA': [28, 89], '200': [30], 'mg': [31, 39], '(FIL200);': [32], 'however,': [33], 'starting': [35], '100': [38, 385], '(FIL100)': [40], 'those': [44, 258, 267, 300, 646], 'aged': [45, 90, 149, 193, 259, 268, 293, 301, 647], '≥75': [46, 91, 152, 196, 269, 294, 302, 394, 396, 614, 648], 'years': [47, 386, 392, 604], '(y)': [48], 'in': [49, 69, 86, 147, 154, 224, 232, 247, 257, 266, 291, 345, 645, 664, 692], 'view': [50], 'limited': [52], 'clinical': [53, 166], 'experience': [54], 'An': [57], 'important': [58], 'consideration': [59], 'generally': [62, 217, 289, 630], 'higher': [63, 238, 290, 320, 631, 644], 'incidence': [64, 276, 326, 373, 637], 'adverse': [66, 329, 527, 609], 'events': [67, 383, 546], '(AEs)': [68], 'elderly': [71], 'due': [72], 'comorbidities.': [74], 'Objectives': [75], 'To': [76], 'evaluate': [77], 'efficacy': [79, 144, 210, 621], 'and': [80, 84, 109, 143, 151, 177, 189, 195, 227, 235, 251, 255, 262, 264, 282, 316, 334, 341, 544, 628, 641, 688, 709, 731, 743, 754, 762, 768, 784, 794, 805, 811, 824, 830, 847, 864, 880, 886, 925, 943, 955, 969], 'safety': [81, 142], 'FIL100': [83, 108, 252, 390], 'FIL200': [85, 110, 240, 250, 322, 357, 389, 633], 'patients': [87, 114, 148, 192, 225, 292, 352, 689], 'y.': [92, 298, 651], 'Methods': [93], 'FINCH': [94, 155, 233, 672], '4': [95], '(': [96], 'NCT03025308': [97], ')': [98], 'an': [100], 'ongoing': [101], 'phase': [102, 118], '3': [103, 119], 'open-label': [104], 'LTE': [105, 185, 213, 220], 'study': [106, 122, 311, 454], 'RA.': [112], 'Eligible': [113], 'completed': [115], 'prior': [117, 229, 410], 'randomized': [120], 'double-blind': [121], 'FIL': [124, 230, 411], 'lasting': [125], '52': [126], 'weeks': [127, 134], '(FINCH': [128, 135], 'or': [130, 132], '3)': [131], '24': [133], '2).': [136], 'In': [137, 202, 299, 612], 'this': [138], 'post': [139], 'hoc': [140], 'analysis,': [141], 'were': [145, 159, 199, 216, 236, 629, 674], 'assessed': [146], '<75': [150, 194, 260, 297, 393, 395, 650], 'y': [153, 261, 295, 615], '4.': [156], 'Efficacy': [157], 'measures': [158, 211, 622], 'American': [160], 'College': [161], 'Rheumatology': [163], '(ACR)20/50/70': [164], 'responses,': [165], 'disease': [167, 172], 'activity': [168, 173], 'index': [169, 181], '(CDAI)': [170], '≤10/≤2.8,': [171], 'score': [174], '(DAS)28': [175], '<2.6/≤3.2': [176], 'health': [178], 'assessment': [179], 'questionnaire-disability': [180], '(HAQ-DI).': [182], 'Results': [183], 'At': [184], 'Week': [186, 214, 380, 626], '48,': [187], '52%': [188], '44%': [190], 'y,': [197, 270, 303], 'respectively,': [198], 'on': [200], 'methotrexate.': [201], 'both': [203, 346], 'age': [204], 'groups,': [205], 'response': [206, 617], 'rates': [207, 618], 'key': [209, 620], 'at': [212, 379], '48': [215, 381, 627], 'maintained': [218], 'from': [219, 245, 355], 'baseline': [221, 246], '(Figure': [222], '1)': [223], 'without': [228], 'exposure': [231, 388], '1–3,': [234], 'numerically': [237], 'vs': [241, 323, 634], 'FIL100.': [242, 635], 'Mean': [243], 'change': [244], 'HAQ-DI': [248], 'was': [253, 288, 319, 343, 643, 698], '0.61': [254], '0.74': [256], '1.04': [263], '0.98': [265], 'respectively.': [271], 'Figure': [272], '1.': [273, 371], 'exposure-adjusted': [275], 'rate': [277, 374], '(EAIR)': [278], 'serious': [280, 317, 337, 639], 'AEs': [281, 283, 307, 314, 378, 640], 'special': [285], 'interest': [286], '(AESI)': [287], 'than': [296, 649], 'EAIR': [305], 'leading': [308, 451, 469], 'premature': [310, 453], 'discontinuation,': [312], 'treatment-emergent': [313], '(TEAEs),': [315], 'TEAEs': [318], 'FIL100;': [324], 'major': [328, 526], 'cardiovascular': [330, 528], 'events,': [331, 336], 'venous': [332], 'thrombotic': [333, 543], 'embolic': [335, 545], 'infections,': [338], 'herpes': [339], 'zoster': [340, 512], 'malignancies': [342], 'low': [344], 'groups': [348], '(Table': [349], '1).': [350], 'Three': [351], 'died,': [353], 'all': [354], 'group;': [358], 'each': [359], 'had': [360], 'medical': [362], 'history': [363], 'relevant': [364], 'cause': [367], 'death.': [369], 'Table': [370], 'Exposure-adjusted': [372], '(95%': [375], 'CI)': [376], 'as': [382], 'per': [384], 'Age,': [391], 'n=1469': [397], 'n=61': [398], 'n=1136': [399], 'n=63': [400], '(PYE': [401, 403, 405, 407], '2253.9)': [402], '92.2)': [404], '1753.7)': [406], '98.4)': [408], 'With': [409], 'exposure,': [412], 'n': [413], '(%)': [414], '1142': [415], '(77.7)': [416], '53': [417], '(86.9)': [418], '830': [419], '(73.1)': [420], '33': [421], '(52.4)': [422], 'TEAE': [423, 437], '48.3': [424], '(45.5,': [425, 431], '51.3)': [426], '55.3': [427], '(42.1,': [428], '72.8)': [429], '48.7': [430], '52.1)': [432], '42.7': [433], '(31.6,': [434], '57.8)': [435], 'Serious': [436, 497], '6.8': [438], '(5.8,': [439], '8.0)': [440], '17.4': [441], '(10.6,': [442], '28.3)': [443], '7.4': [444], '(6.2,': [445], '8.7)': [446, 504, 518, 535, 552], '14.2': [447], '(8.4,': [448], '24.0)': [449], 'AE': [450, 468], 'discontinuation': [455], '2.9': [456], '(2.3,': [457], '3.7)': [458], '9.8': [459], '(5.1,': [460], '18.8)': [461], '3.9': [462], '(3.1,': [463], '5.0)': [464], '4.1': [465], '(1.5,': [466], '10.8)': [467], 'death': [471], '0.5': [472, 536], '(0.3,': [473], '0.9)': [474, 538], '3.3': [475], '(0.7,': [476], '9.5)*': [477], '0.3': [478, 547], '(0.2,': [479, 531, 537, 576], '0.8)': [480, 577], '0.0': [481, 584], '(0.0,': [482, 579, 585], '3.8)': [483, 586], 'Infections': [484], '28.8': [485], '(26.6,': [486], '31.1)': [487], '29.3': [488], '(20.1,': [489], '42.7)': [490], '27.4': [491], '(25.0,': [492], '29.9)': [493], '26.4': [494], '(18.0,': [495], '38.8)': [496], 'infections': [498], '1.6': [499, 513], '(1.2,': [500, 514], '2.2)': [501], '2.2': [502, 516, 533, 550], '(0.5,': [503, 517, 534, 551], '1.7': [505], '(1.1,': [506], '2.4)': [507], '3.1': [508, 522, 571], '(1.0,': [509, 523, 572], '9.5)': [510, 524, 573], 'Herpes': [511], '2.3)': [515], '1.0': [519, 539, 556], '(0.6,': [520], '1.6)': [521], 'Adjudicated': [525], 'event': [529, 610], '0.4': [530, 575], '0.7)': [532], '(0.1,': [540, 548, 554, 557, 582], '7.2)': [541, 558], 'Venous': [542], '0.6)': [549, 583], '0.2': [553, 581], '0.5)': [555], 'Malignancy': [559], 'excluding': [560], 'NMSC': [561, 574], '0.7': [562, 568], '(0.4,': [563, 569], '1.2)': [564, 570], '4.3': [565], '(1.6,': [566], '11.6)': [567], '1.1': [578], '6.0)': [580], '*Cause': [587], 'death:': [589], 'esophageal': [590], 'carcinoma;': [591], 'cardiovascular;': [592], 'unknown.': [593], 'FIL(100/200),': [594], 'filgotinib': [595], '(100/200': [596], 'mg);': [597], 'NMSC,': [598], 'nonmelanoma': [599], 'skin': [600], 'cancer;': [601], 'PYE,': [602], 'patient': [603], 'exposure;': [606], '(TE)AE,': [607], '(treatment-emergent)': [608], 'Conclusion': [611], 'group,': [616], 'remained': [623], 'stable': [624], 'AESI': [642], 'Patient': [652], 'numbers/exposure': [653], 'time': [654], 'may': [655], 'have': [656], 'been': [657], 'insufficient': [658], 'show': [660], 'potential': [661], 'between-group': [662], 'differences': [663], 'safety/efficacy': [665], 'outcomes.': [666], 'References': [667], '[1]Filgotinib': [668], 'SmPC': [669], 'Acknowledgements': [670], 'studies': [673], 'funded': [675, 710], 'by': [676, 700, 711], 'Gilead': [677, 829], 'Sciences': [678], '(Foster': [679], 'City,': [680], 'CA,': [681], 'United': [682], 'States).': [683], 'We': [684], 'thank': [685], 'physicians': [687], 'who': [690], 'participated': [691], 'studies.': [694], 'Medical': [695], 'writing': [696], 'support': [697, 746, 808, 827, 958], 'provided': [699], 'Debbie': [701], 'Sherwood,': [702], 'BSc': [703], '(Aspire': [704], 'Scientific': [705], 'Ltd,': [706], 'Bollington,': [707], 'UK)': [708], 'Galapagos': [712], 'NV': [713], '(Mechelen,': [714], 'Belgium).': [715], 'Disclosure': [716], 'Interests': [718], 'Daniel': [719], 'Aletaha': [720], 'Speakers': [721, 758, 772, 816, 834, 869, 929], 'bureau:': [722, 759, 773, 817, 835, 870, 930], 'AbbVie,': [723, 735, 748, 774, 788, 800, 818, 821, 836, 851, 871, 917, 931, 948, 960], 'Amgen,': [724, 736, 749, 837, 852, 918, 932], 'Lilly,': [725, 737, 750, 778, 791, 804, 842, 858, 875, 921, 940, 952], 'Janssen,': [726, 738, 780, 793, 841, 857], 'Merck,': [727, 739], 'Novartis,': [728, 740, 751, 782, 844, 860, 877], 'Pfizer,': [729, 741, 783, 806, 812, 825, 831, 845, 861, 878, 923], 'Roche,': [730, 742, 752, 862, 879, 885, 924], 'Sandoz,': [732, 744, 846, 863], 'Consultant': [733, 764, 786, 798, 819, 849, 882, 915, 946], 'of:': [734, 765, 787, 799, 820, 850, 883, 892, 897, 902, 905, 910, 916, 947], 'Grant/research': [745, 807, 826, 957], 'from:': [747, 809, 828, 959], 'SoBi,': [753], 'Sanofi,': [755, 881, 887, 926, 954], 'Rene': [756], 'Westhovens': [757], 'Celltrion,': [760, 766, 776, 789, 839, 854], 'Galapagos,': [761, 767, 802, 822, 840, 856, 873, 893, 898, 903, 906, 911, 920], 'Gilead,': [763, 769, 803, 823, 941], 'Bernard': [770], 'Combe': [771], 'BMS,': [775, 801, 838, 853, 872, 919, 936], 'Eli': [777, 790, 939, 951], 'Gilead-Galapagos,': [779, 792], 'MSD,': [781, 843, 859, 876, 922], 'Roche-Chugai,': [785, 795], 'Jacques-Eric': [796], 'Gottenberg': [797], 'BMS': [810], 'Maya': [813], 'H': [814], 'Buch': [815], 'Roberto': [832], 'Caporali': [833], 'UCB,': [848, 865], 'Fresenius-Kabi,': [855], 'José': [866], 'A': [867], 'Gómez-Puerta': [868], 'GSK,': [874, 884, 953], 'Paul': [888], 'Van': [889], 'Hoek': [890], 'Employee': [891, 896, 904, 909], 'Vijay': [894], 'Rajendran': [895], 'Pieter-Jan': [899], 'Stiers': [900], 'Shareholder': [901], 'Thijs': [907], 'Hendrikx': [908], 'Gerd': [912], 'Rüdiger': [913], 'Burmester': [914], 'Yoshiya': [927], 'Tanaka': [928], 'Astellas,': [933], 'Astra-Zeneca,': [934], 'Boehringer-Ingelheim,': [935, 962], 'Chugai,': [937, 963], 'Eisai,': [938, 966], 'Mitsubishi-Tanabe,': [942, 968], 'YL': [944], 'Biologics,': [945], 'Ayumi,': [949], 'Daiichi-Sankyo,': [950, 965], 'Taisho,': [956], 'Asahi-Kasei,': [961], 'Corrona,': [964], 'Kowa,': [967], 'Takeda': [970]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W4283711720', 'counts_by_year': [{'year': 2023, 'cited_by_count': 1}], 'updated_date': '2024-12-25T10:56:06.725029', 'created_date': '2022-06-30'}